Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Brandi Ligon

Nurse Practitioner, Gerontology Winter Park, FL Nurse Practitioner

NPI 1750846077 CMS profile 11079294

2100 Glenwood Dr, Winter Park, FL 32792

Open in the dashboard

General payments

$26,826

397 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brandi Ligon of Winter Park, FL is reported in the CMS Open Payments database as having received $26,826 across 397 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,339 34
2024 General $4,677 40
2023 General $3,453 37
2022 General $9,666 164
2021 General $5,690 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brandi Ligon
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Brandi Ligon were reported at $3,339. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Brandi Ligon Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $5,690 $133 $44–$396 $132
2022 $9,666 $142 $48–$452 $149
2023 $3,453 $158 $53–$482 $160
2024 $4,677 $171 $55–$533 $164
2025 $3,339 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Sobi, Inc $3,557 24 payments
  2. AstraZeneca Pharmaceuticals LP $2,263 35 payments
  3. Janssen Biotech, Inc. $1,668 33 payments
  4. Incyte Corporation $1,660 18 payments
  5. Catalyst Pharmaceuticals, Inc. $1,250 3 payments
  6. Daiichi Sankyo Inc. $924 16 payments
  7. Seattle Genetics, Inc. $922 18 payments
  8. GlaxoSmithKline, LLC. $778 9 payments
  9. Novocure Inc. $773 8 payments
  10. E.R. Squibb & Sons, L.L.C. $694 6 payments
  11. Other $12,337 227 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $21,915 380 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,300 1 payment
  3. Travel and Lodging $1,168 3 payments
  4. Honoraria $1,050 1 payment
  5. Education $993 11 payments
  6. Consulting Fee $400 1 payment
Products named General payments · program years 2021–2025
  1. Doptelet $3,404 24 payments
  2. FIRDAPSE $1,250 3 payments
  3. JAKAFI $863 11 payments
  4. ENHERTU $711 14 payments
  5. ERLEADA $694 11 payments
  6. ADCETRIS $545 9 payments
  7. clonoSEQ $491 2 payments
  8. KEYTRUDA $489 9 payments
  9. REBLOZYL $435 7 payments
  10. MONJUVI $431 6 payments
  11. Other $16,003 340 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$41,429

Medicare's payments for the services billed

Medicare patients

291

Average age 77

Services billed

809

148 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 62%
Ischemic heart disease 59%
Arthritis 59%
Heart failure 52%
Atrial fibrillation 45%
Depression 45%
Diabetes 44%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 25 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
FIRDAPSE
  • CATALYST PHARMACEUTICALS, INC. $1,158
$1,158 — —
ENHERTU
  • Daiichi Sankyo Inc. $174
  • AstraZeneca Pharmaceuticals LP $112
$286 — —
VONJO
  • Sobi, Inc $194
$194 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $175
$175 — —
CABOMETYX
  • Exelixis Inc. $158
$158 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 25 in the dashboard with a free account

Records

397 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Gerontology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record